Literature DB >> 22938995

Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri.

Pierre-Marie Allard1, Pieter Leyssen, Marie-Thérèse Martin, Mélanie Bourjot, Vincent Dumontet, Cécilia Eydoux, Jean-Claude Guillemot, Bruno Canard, Cyril Poullain, Françoise Guéritte, Marc Litaudon.   

Abstract

The chemical study of the bark and the wood of Trigonostemon cherrieri, a rare endemic plant of New Caledonia, led to the isolation of a series of highly oxygenated daphnane diterpenoid orthoesters (DDO) bearing an uncommon chlorinated moiety: trigocherrins A-F and trigocherriolides A-D. Herein, we describe the isolation and structure elucidation of the DDO (trigocherrins B-F and trigocherriolides A-D). We also report the antiviral activity of trigocherrins A, B and F (1, 2 and 6) and trigocherriolides A, B and C (7-9) against various emerging pathogens: chikungunya virus (CHIKV), Sindbis virus (SINV), Semliki forest virus (SFV) and dengue virus (DENV).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938995     DOI: 10.1016/j.phytochem.2012.07.023

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  19 in total

1.  Mining in New Caledonia: environmental stakes and restoration opportunities.

Authors:  Guillaume Losfeld; Laurent L'Huillier; Bruno Fogliani; Tanguy Jaffré; Claude Grison
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-29       Impact factor: 4.223

2.  Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.

Authors:  Daryl Staveness; Rana Abdelnabi; Katherine E Near; Yu Nakagawa; Johan Neyts; Leen Delang; Pieter Leyssen; Paul A Wender
Journal:  J Nat Prod       Date:  2016-02-22       Impact factor: 4.050

Review 3.  Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective.

Authors:  Soumendranath Bhakat; Mahmoud E S Soliman
Journal:  J Nat Med       Date:  2015-04-29       Impact factor: 2.343

Review 4.  Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses.

Authors:  Ana Flávia Costa da Silveira Oliveira; Róbson Ricardo Teixeira; André Silva de Oliveira; Ana Paula Martins de Souza; Milene Lopes da Silva; Sérgio Oliveira de Paula
Journal:  Molecules       Date:  2017-03-22       Impact factor: 4.411

Review 5.  Antivirals against Chikungunya Virus: Is the Solution in Nature?

Authors:  Daniel Oliveira Silva Martins; Igor de Andrade Santos; Débora Moraes de Oliveira; Victória Riquena Grosche; Ana Carolina Gomes Jardim
Journal:  Viruses       Date:  2020-02-29       Impact factor: 5.048

6.  In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2).

Authors:  Kingshuk Panda; Kalichamy Alagarasu; Poonam Patil; Megha Agrawal; Ashwini More; Naveen V Kumar; Prathama S Mainkar; Deepti Parashar; Sarah Cherian
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

7.  Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors.

Authors:  T Agarwal; Somya Asthana; A Bissoyi
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

Review 8.  Current Strategies for Inhibition of Chikungunya Infection.

Authors:  Bharat Bhusan Subudhi; Soma Chattopadhyay; Priyadarsee Mishra; Abhishek Kumar
Journal:  Viruses       Date:  2018-05-03       Impact factor: 5.048

9.  Resveratrol affects Zika virus replication in vitro.

Authors:  Azirah Mohd; Nurhafiza Zainal; Kim-Kee Tan; Sazaly AbuBakar
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

Review 10.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.